Search
for
Sort by
Research 30 of 1000+
- Chronic telogen effluvium: Increased scalp hair shedding in middle-aged women
- “Shedding” low yield testing for telogen effluvium: A cross-sectional study of 16,381 laboratory results from newly diagnosed patients
- A 2% Oleosome-FGF-2 Fusion Extract Scalp Serum Improves Photo-trichogramDerived Hair Density, Anagen/Telogen Ratio, Hair Shaft Thickness, and Scalp Barrier Parameters in Women with Shedding-Prone Hair: A Randomized, SingleBlind, Placebo-Controlled Pilot Study
- Telogen effluvium
- Telogen Effluvium
- Localized Telogen Effluvium Following Hair Transplantation
- Thiol/disulfide homeostasis in patients with telogen effluvium: is oxidative stress important in the pathogenesis of telogen effluvium?
- SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
- Telogen effluvium: a review
- Interest of a vitamin and mineral supplement in the management of telogen effluvium: Clinical study on Brazilian women
- Telogen effluvium: a comprehensive review
- Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study
- Telogen effluvium in the new SARS‐CoV‐2 era
- Hair Shedding Evaluation for Alopecia: A Refined Wash Test
- Telogen Effluvium
- Role of individualized homeopathy in stress-associated telogen effluvium
- Modeling Oxidative Stress-Linked Telogen Effluvium Using Monte Carlo Simulation of Published Trichoscopy Norms and Cannabis Exposure Distributions
- Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation
- Telogen Effluvium
- CHRONIC TELOGEN EFFLUVIUM
- Telogen effluvium: a sequela of COVID‐19
- Teloptosis, a Turning Point in Hair Shedding Biorhythms
- EEMCO Guidance for the Assessment of Hair Shedding and Alopecia
- Telogen effluvium associated with COVID‐19 infection
- Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations
- Seasonality of Hair Shedding in Healthy Women Complaining of Hair Loss
- Trichodynia is a distinguishing symptom of telogen effluvium
- Regulation of Hair Shedding by the Type 3 IP3 Receptor
- Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore<sup>®</sup>, improves telogen effluvium‐associated parameters
- Intermittent Chronic Telogen Effluvium